NASDAQ : AMGN
Amgen Inc. — Key statistics
Healthcare · Drug Manufacturers - General · United States
Last price 466.01 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 251.94B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 251.94B |
| Enterprise Value | 295.25B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | Nov 20, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 540.63M |
| Shares Outstanding | 540.63M |
| Shares Change (YoY) | +0.46% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.17% |
| Owned by Institutions (%) | 83.71% |
| Float | 539.16M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 28.95 |
| Forward PE | 19.76 |
| PS Ratio | 6.61 |
| Forward PS | 6.27 |
| PB Ratio | 21.55 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 24.76 |
| P/OCF Ratio | 20.19 |
| PEG Ratio | 4.01 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 33.77 |
| EV / Sales | 7.75 |
| EV / EBITDA | 17.10 |
| EV / EBIT | 23.20 |
| EV / FCF | 29.02 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.37 |
| Quick Ratio | 0.95 |
| Debt / Equity | 4.90 |
| Debt / EBITDA | 3.27 |
| Debt / FCF | 5.63 |
| Interest Coverage | 4.14 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 91.47% |
| Return on Assets (ROA) | 8.67% |
| Return on Invested Capital (ROIC) | 19.76% |
| Return on Capital Employed (ROCE) | 18.14% |
| Weighted Average Cost of Capital (WACC) | 6.13% |
| Revenue Per Employee | $1.21M |
| Profits Per Employee | $277,556 |
| Employee Count | 31,500 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 1.67 |
Taxes
| Measure | Value |
|---|
| Income Tax | 1.54B |
| Effective Tax Rate | 15.01% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.41 |
| 52-Week Price Change | +59.72% |
| 50-Day Moving Average | 419.96 |
| 200-Day Moving Average | 374.79 |
| Relative Strength Index (RSI) | 71.43 |
| Average Volume (20 Days) | 2,614,522 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 13.38M |
| Short Previous Month | 14.03M |
| Short % of Shares Out | 2.47% |
| Short % of Float | 2.48% |
| Short Ratio (days to cover) | 4.35 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 38.10B |
| Gross Profit | 27.39B |
| Operating Income | 12.73B |
| Pretax Income | 10.29B |
| Net Income | 8.74B |
| EBITDA | 17.27B |
| EBIT | 12.73B |
| Earnings Per Share (EPS) | $16.09 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 13.99B |
| Total Debt | 57.30B |
| Net Cash | -43.32B |
| Net Cash Per Share | -$80.12 |
| Equity (Book Value) | 11.69B |
| Book Value Per Share | 21.62 |
| Working Capital | 9.46B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 12.48B |
| Capital Expenditures | -2.30B |
| Depreciation & Amortization | 4.54B |
| Net Borrowing | 1.32B |
| Free Cash Flow | 10.18B |
| FCF Per Share | $18.82 |
Margins
| Measure | Value |
|---|
| Gross Margin | 71.89% |
| Operating Margin | 33.40% |
| Pretax Margin | 27.00% |
| Profit Margin | 22.95% |
| EBITDA Margin | 45.33% |
| EBIT Margin | 33.40% |
| FCF Margin | 26.71% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $10.08 |
| Dividend Yield | 2.16% |
| Dividend Growth (YoY) | 5.88% |
| Years of Dividend Growth | 15 |
| Payout Ratio | 62.63% |
| FCF Payout Ratio | 53.56% |
| Buyback Yield | -0.46% |
| Shareholder Yield | 1.70% |
| Earnings Yield | 3.45% |
| FCF Yield | 4.04% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $397.32 |
| Price Target Difference | -14.74% |
| Analyst Consensus | Hold |
| Analyst Count | 34 |
| Revenue Growth Forecast (3Y) | 4.45% |
| EPS Growth Forecast (3Y) | 5.85% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Nov 22, 1999 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.89 |
| Piotroski F-Score | 8 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |